An individual with factor V Leiden thrombophilia is more likely to develop a blood clot at some point in their lives. In the event of a clot forming, it usually occurs in the legs (deep vein thrombosis or DVT) or the lungs (pulmonary embolism or PE). Factor V Leiden refers to a mutation in the FS gene that causes blood clots to form after injury. One or two copies of the Factor V Leiden gene mutation can be inherited. The condition is sometimes misdiagnosed as Factor V deficiency, a genetic bleeding disorder that can cause severe bleeding after surgery. Heart attacks, strokes, and pregnancy complications may be associated with Factor V Leiden thrombophilia. COVID-19 has also seen a dramatic increase in demand for commonly used drugs such as Hydroxychloroquine. As many developed countries face shortages of these drugs, such a high demand has provided huge opportunities for manufacturers of COVID-19 management drugs. Due to the need for vaccines and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to grow significantly in the future. Consequently, the global market for Factor V Leiden thrombophilia treatment will be affected significantly. Injuries, obesity, smoking, surgery, and pregnancy are driving the market expansion, as are an increase in geriatrics and cases of injury, obesity, smoking, and pregnancy. A surge in the diabetic population, an increase in cancer patients, and an increase in the prevalence of cardiovascular disease are factors driving the market's growth. During the forecast period, the factor V Leiden thrombophilia treatment market will be driven by the growing number of mutations in the FS gene. Also expected to boost the market over the forecast period are the increasing use of oral contraceptives, hormone replacement treatment, and the incidence of antiphospholipid syndrome. Further, new medications, increased research and development activities, and increased investment by major companies for Factor V Leiden thrombophilia treatment are boosting the global market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Factor V Leiden Thrombophilia Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Factor V Leiden Thrombophilia Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.